Medical University of Graz
Graz, 8036, Austria
Location status: Recruiting
Location contact
Daniel Scherr, Assoc.Prof. PD Dr.
CONTACT
NCT Number: NCT03409159
Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Graz, 8036, Austria
Location status: Recruiting
Daniel Scherr, Assoc.Prof. PD Dr.
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Left atrial appendage closure
Time frame: 30 days
Time frame: 5 years
Time frame: 30 days
Contact information is provided by the study sponsor or research team.
Medical University of Graz
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07575867
Anticoagulants / Administration & Dosage, Arrhythmias, Cardiac
Moscow, Russia
View Trial DetailsNCT06293430
Arrhythmias, Cardiac, Atrial Arrhythmia
View Trial DetailsNCT05931835
Arrhythmias, Cardiac, Atrial Arrhythmia
Dublin, Leinster, Ireland
View Trial DetailsNCT07126600
Arrhythmias, Cardiac, Atrial Fibrillation
Jonesboro, Arkansas, United States
View Trial Details